ULTOMIRIS
ULTOMIRIS
Approved
DIN Number
02491559
Drug Class
Human
Market Date
Sep 9, 2021
Company
HC
Alexion Pharma GmbH
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02491559
AIG Number0161710001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L04AJ02 RAVULIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification90:20.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
RAVULIZUMABActive
Strength: 10 MG / ML
Monograph: RAVULIZUMAB